NYSE:MRK Merck & Co., Inc. Q3 2026 Earnings Report $142.82 -0.99 (-0.68%) As of 11:03 AM Eastern This is a fair market value price provided by Massive. Learn more. ProfileEarnings HistoryForecast Merck & Co., Inc. EPS ResultsActual EPSN/AConsensus EPS $2.19Beat/MissN/AOne Year Ago EPSN/AMerck & Co., Inc. Revenue ResultsActual RevenueN/AExpected Revenue$17.31 billionBeat/MissN/AYoY Revenue GrowthN/AMerck & Co., Inc. Announcement DetailsQuarterQ3 2026Date10/29/2026TimeBefore Market OpensConference Call DateThursday, October 29, 2026Conference Call Time9:00AM ETConference Call ResourcesEarnings HistoryCompany Profile Merck & Co., Inc. Earnings HeadlinesMerck's Tulisokibart Meets Endpoints in Hidradenitis Suppurativa StudyOctober 1 at 12:51 PM | finance.yahoo.comJNJ or MRK: One Dividend Is Built to Last, One Faces a ReckoningOctober 1 at 12:51 PM | 247wallst.comThe SEC Just Opened The Floodgates…The SEC removed the 25 year old Pattern Day Trader rule in June 2026, cutting the minimum to open a trading account to just 2,000 dollars. Small cap stocks like ONFO, CURR, RMSG, TMDE and VSME have already posted gains ranging from 140 percent to 482 percent, some in a single day. Tim Bohen, known for flagging Tesla at 37 and Nvidia at 6.93, believes this shift could trigger the next major small cap breakout.October 2 at 1:00 AM | StocksToTrade (Ad)Merck's Tulisokibart Data From Hidradenitis Suppurativa Trial Looks Solid, UBS Securities SaysOctober 1 at 12:51 PM | finance.yahoo.comJNJ or MRK: One Dividend Is Built to Last, One Faces a ReckoningOctober 1 at 12:15 PM | 247wallst.comMerck to Hold Third-Quarter 2026 Sales and Earnings Conference Call Oct. 29October 1 at 7:00 AM | businesswire.comSee More Merck & Co., Inc. Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Merck & Co., Inc.? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Merck & Co., Inc. and other key companies, straight to your email. Email Address About Merck & Co., Inc.Merck & Co., Inc. (NYSE:MRK) is a global healthcare company that develops and markets prescription medicines, vaccines, and animal-health products. The company serves patients, healthcare providers, and customers in markets around the world, with research and commercial operations spanning multiple geographic regions. Its pharmaceutical portfolio includes oncology, infectious-disease, cardiovascular, immunology, and other therapeutic areas. Key products include Keytruda, an oncology treatment; Gardasil, a human papillomavirus (HPV) vaccine; Januvia and Janumet for type 2 diabetes; Bridion for anesthesia-related use; and Winrevair for pulmonary arterial hypertension. Merck also operates an animal-health business that provides veterinary pharmaceuticals, vaccines, and health-management solutions for livestock and companion animals. Founded in 1891, Merck & Co. is headquartered in Rahway, New Jersey. It is a separate company from Merck KGaA, the Germany-based healthcare and life-sciences company. Robert M. Davis has served as Merck & Co.’s chairman and chief executive officer since 2021.View Merck & Co., Inc. ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles Micron’s Earnings Reveal Why the AI Memory Boom May Last LongerAnthropic's IPO Could Put Amazon's and Alphabet's Paper Profits to the TestBoeing’s Fighter Victory Opens the Door to Decades of Defense RevenueCleared for Takeoff: AAR Corp. Expands Its Aerospace Aftermarket ReachJabil’s Double-Beat and Raise Is a Signal That This Rally Will ContinueMicrosoft's AI Spending Didn't Change—Wall Street's View of It DidL3Harris’ $6 Billion THAAD Win Comes at a Crucial Moment for the Stock Upcoming Earnings PepsiCo (10/8/2026)Delta Air Lines (10/9/2026)America Movil (10/13/2026)Citigroup (10/13/2026)The Goldman Sachs Group (10/13/2026)JPMorgan Chase & Co. (10/13/2026)Wells Fargo & Company (10/13/2026)Johnson & Johnson (10/13/2026)UnitedHealth Group (10/13/2026)Bank of America (10/14/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
